Welcome to the MDI website. Content and updating of information is ongoing on our website, therefore if you cannot find what you are looking for please contact us.

Second booster vaccine available for over 65’s and those with a weakened immune system

People aged 65 years and over are now eligible for their second COVID-19 booster vaccine. Those with a weak immune system aged 12 and over can also get their second booster, when it is due. Those who are due their second COVID-19 booster vaccine can: Visit the following link for more information https://www2.hse.ie/screening-and-vaccinations/covid-19-vaccine/get-the-vaccine/covid-19-vaccine-booster-dose/ Book a […]

COVID-19 vaccine booster for 12 to 15-year-olds

All children aged 12 to 15 are being offered a COVID-19 vaccine booster. The protection that your child has from their initial COVID-19 vaccines may weaken over time. Their booster dose should give them better protection and reduce their chances of getting seriously ill. It is especially important for children with high risk health conditions, […]

Treatment for people at the highest risk from COVID-19: HSE update

A new medicine is available to treat people with COVID-19 (coronavirus) who are at the highest risk of becoming seriously ill. Sotrovimab is also known by the brand name Xevudy. It is the first type of COVID-19 medicine available in Ireland. You’ll be told by your doctor or consultant if this medicine is for you. Other COVID-19 […]

Treatment for people at the highest risk from COVID-19

Treatment for people at the highest risk from COVID-19 A new medicine is available to treat people with COVID-19 (coronavirus) who are at the highest risk of becoming seriously ill. Sotrovimab is also known by the brand name Xevudy. It is the first type of COVID-19 medicine available in Ireland. You’ll be told by your doctor […]

COVID-19 booster (4th) dose

COVID-19 booster (4th) dose for people who are immunocompromised (have a weak immune system) People who have a weak immune system, also called immunocompromised, can now get a booster (4th) dose. People in this group were offered an additional dose of the COVID-19 vaccine last year, and can now get a booster dose if it […]

IMPORTANT COVID-19 UPDATES FROM HSE

Changes to isolation and close contact rules: From today, Friday 14th January, the rules around self-isolation and close contacts have changed. As before, if you have symptoms of COVID-19 you should immediately self-isolate and get tested. People aged 0-3 and people aged 40 and over and all healthcare workers should get a PCR test. People aged 4-39 […]

COVID-19 vaccine boosters

People aged 60 or over and healthcare workers are currently being offered a COVID-19 vaccine booster dose at least 5 months after their last vaccine. If you have had COVID-19, and you’re due to get a booster vaccine dose, you’ll need to wait until around 6 months after your positive test result. People with high-risk […]

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy
  •     •  General
  •     •  MDC1A (merosin-deficient congenital muscular dystrophy)
  •     •  Rigid spine syndrome (RSS)
  •     •  Ullrich congenital muscular dystrophies
  •     •  Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy
  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD)
  •     •  General
  •     •  LGMD 1B (also known as Laminopathy)
  •     •  LGMD 1C (also known as Caveolinopathy)
  •     •  LGMD 2A (also known as Calpainopathy)
  •     •  LGMD 2B (also known as Dysferlinopathy)
  •     •  LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Congenital Fibre-type Disproportion Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositis

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Friedreich’s Ataxia

12. Other (Please Specify)

13. Unspecified